GelStat Corp. (GSAC)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0001 (-25.00%)
Jul 17, 2025, 12:31 PM EDT
GelStat Revenue
In the year 2024, GelStat had annual revenue of $349.73K with 133.89% growth. GelStat had revenue of $117.25K in the quarter ending December 31, 2024, with 87.78% growth.
Revenue
349.73K
Revenue Growth
+133.89%
P/S Ratio
4.28
Revenue / Employee
174.87K
Employees
2
Market Cap
1.50M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
GelStat News
- 5 weeks ago - GSAC Engineering Secures Multi-Year Recurring Revenue Contract - GlobeNewsWire
- 2 years ago - GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group - GlobeNewsWire
- 2 years ago - GelStat Forms New and Advanced Engineering Division - GlobeNewsWire
- 3 years ago - GelStat Provides Corporate Update on Capital Restructuring - GlobeNewsWire